Hepatitis B: Expanding the Donor Pool and the Therapeutic Pipeline

Dr. Nancy Reau reviews how transplant programs are safely using donor organs with prior hepatitis B exposure and surface antigen positivity, then turns to the developing therapeutic pipeline and what it may mean for selected patients. In this segment: Reactivation risk with core antibody positive donors and how prophylaxis lowers it The expanding use of surface antigen positive grafts and the outcomes data Why hepatitis B is biologically difficult to clear The major mechanistic approaches now in development Early data from a finite-course investigational approach in a well-selected population, and a look at gene editing now entering humans Speaker: Dr. Nancy Reau, Professor of Internal Medicine and Richard B. Capps Chair of Hepatology, Rush University Medical Center, Chicago. This material is intended for healthcare professionals for educational purposes only and is not medical advice. For the full video visit https://www.inedsys.com #Hepatology #LiverTransplant #HepatitisB #CME